Clinical relevance of detectable HCV RNA in the context of direct acting antivirals.
| Data(s) |
17/06/2016
17/06/2016
14/07/2012
29/01/2013
|
|---|---|
| Formato |
application/pdf |
| Identificador |
O'Sullivan, K., Levis, J., Hegarty, K., Crosbie, O., Kenny-Walsh, E. and Fanning, L. J. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57, pp. 855–856. http://dx.doi.org/10.1002/hep.25942 57 2 855 856 0270-9139 1527-3350 http://hdl.handle.net/10468/2759 10.1002/hep.25942 Hepatology |
| Idioma(s) |
en |
| Publicador |
Wiley |
| Direitos |
© 2012 by the American Association for the Study of Liver Diseases. This is the pre-peer reviewed version of the following article: O’Sullivan et al. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57: 855–856, which has been published in final form at doi:10.1002/hep.25942. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
| Palavras-Chave | #HCV #Hepacivirus #Hepatitis C, #Oligopeptides #RNA |
| Tipo |
Article (peer-reviewed) |
